Literature DB >> 16075310

Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model.

Viktor Kettmann1, Daniela Kost'álová, Hans-Dieter Höltje.   

Abstract

Using the X-ray crystal structure of the human topoisomerase I (top1) - DNA cleavable complex and the Sybyl software package, we have developed a general model for the ternary cleavable complex formed with four protoberberine alkaloids differing in the substitution on the terminal phenyl rings and covering a broad range of the top1-poisoning activities. This model has the drug intercalated with its planar chromophore between the -1 and +1 base pairs flanking the cleavage site, with the nonplanar portion pointing into the minor groove. The ternary complexes were geometry-optimized and relative interaction energies, computed by using the Tripos force field, were found to rank in correct order the biological potency of the compounds; in addition, the model is also consistent with the top1-poisoning inactivity of berberine, a major prototype of the protoberberine alkaloids. The model might serve as a rational basis for elaboration of the most active compound as a lead structure, in order to develop more potent top1 poisons as next generation anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075310     DOI: 10.1007/s10822-004-7878-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  27 in total

1.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

2.  In vitro cytotoxicity of the protoberberine-type alkaloids.

Authors:  K Iwasa; M Moriyasu; T Yamori; T Turuo; D U Lee; W Wiegrebe
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

3.  Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.

Authors:  Gary S Laco; Jack R Collins; Brian T Luke; Heiko Kroth; Jane M Sayer; Donald M Jerina; Yves Pommier
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

4.  A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.

Authors:  J E Kerrigan; D S Pilch
Journal:  Biochemistry       Date:  2001-08-21       Impact factor: 3.162

5.  Antimicrobial properties of alkaloids from Xanthorhiza simplicissima.

Authors:  A L Okunade; C D Hufford; M D Richardson; J R Peterson; A M Clark
Journal:  J Pharm Sci       Date:  1994-03       Impact factor: 3.534

6.  Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells.

Authors:  I W Yang; C C Chou; B Y Yung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

7.  Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.

Authors:  A J Ryan; S Squires; H L Strutt; R T Johnson
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

8.  Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells.

Authors:  M M Sanders; A A Liu; T K Li; H Y Wu; S D Desai; Y Mao; E H Rubin; E J LaVoie; D Makhey; L F Liu
Journal:  Biochem Pharmacol       Date:  1998-11-01       Impact factor: 5.858

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.

Authors:  Y Kobayashi; Y Yamashita; N Fujii; K Takaboshi; T Kawakami; M Kawamura; T Mizukami; H Nakano
Journal:  Planta Med       Date:  1995-10       Impact factor: 3.352

View more
  8 in total

1.  5-Amino-1-methyl-1H-benzimidazole.

Authors:  Jan Lokaj; Viktor Kettmann; Viktor Milata; Tomáš Solčan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-08

2.  1-Methyl-6-nitro-1H-benzimidazole.

Authors:  Jan Lokaj; Viktor Kettmann; Tomáš Solčan; Svetozar Katuščák
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-05

3.  The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants.

Authors:  Naomi Inoue; Takeshi Terabayashi; Yuri Takiguchi-Kawashima; Daisuke Fujinami; Shigeru Matsuoka; Masanori Kawano; Kazuhiro Tanaka; Hiroshi Tsumura; Toshimasa Ishizaki; Hisashi Narahara; Daisuke Kohda; Yoshihiro Nishida; Katsuhiro Hanada
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

Review 4.  A Review on Traditionally Used African Medicinal Plant Annickia chlorantha, Its Phytochemistry, and Anticancer Potential.

Authors:  Paromita Sarbadhikary; Blassan P George
Journal:  Plants (Basel)       Date:  2022-09-02

5.  Synthesis, characterization and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum(ii) complexes.

Authors:  Miral V Lunagariya; Khyati P Thakor; Reena R Varma; Bhargav N Waghela; Chandramani Pathak; Mohan N Patel
Journal:  Medchemcomm       Date:  2017-12-20       Impact factor: 3.597

6.  Assessment of free radical scavenging and anti-proliferative activities of Tinospora cordifolia Miers (Willd).

Authors:  Picheswara Rao Polu; Udupa Nayanbhirama; Saleemulla Khan; Rajlexmi Maheswari
Journal:  BMC Complement Altern Med       Date:  2017-09-11       Impact factor: 3.659

7.  The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods.

Authors:  Adebayo A Adeniyi; Peter A Ajibade
Journal:  Bioinorg Chem Appl       Date:  2018-06-04       Impact factor: 7.778

8.  Mechanism study of goldenseal-associated DNA damage.

Authors:  Si Chen; Liqing Wan; Letha Couch; Haixia Lin; Yan Li; Vasily N Dobrovolsky; Nan Mei; Lei Guo
Journal:  Toxicol Lett       Date:  2013-06-05       Impact factor: 4.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.